News / Health

Common Form of Leukemia Could be Treatable With New Pill

Jessica Berman
An experimental pill could turn a lethal cancer into a chronic, but manageable disease like high blood pressure.  If approved for treatment for a common form of leukemia, the compound replaces toxic chemotherapy treatments.  

Chronic lymphocytic leukemia, or CLL, is a cancer of the immune system’s B cells, which produce antibodies, the frontline soldiers against bacterial and viral invaders.  But when B cells become cancerous, they accumulate in the patient’s organs, including the lymph nodes, pea-shaped organs under the arms and in the groin that help the body recognize and fight infections.  With CLL, the nodes swell many times their normal size.

Richard Furman, a cancer researcher at Weill Cornell Medical College in New York, says the drug idelalisib, taken twice a day, causes the cancer to melt away.

“When I say melt away, you can literally see the lymph nodes shrink over the course of a couple of days.  It works that quickly, which is really wonderful," said Furman.

The standard treatment for CLL is Rituxan,  an infusion drug that destroys diseased B cells, but only for a time before the patient relapses.  With repeated rounds of chemotherapy, Furman says the leukemia eventually becomes resistant to Rituxan and patients no longer respond.  The cancer is fatal.

Investigators led by Furman compared a combination of idelalisib and Rituxan, to Rituxan and placebo in a group of 220 CLL patients from around the world (19 medical centers in the U.S. and five other countries).

Six months into the study, 13 percent of those receiving only Rituxan responded to the therapy compared to 81 percent of the Idelalisib combination group.  

And 92 percent of participants in that group were still alive a year after the study began, compared to 80 percent in the Rituxan-only group.

The contrast was so significant that the study was halted early so all the patients could receive Idelalisib.

“And with an agent like idelalisib, which is extraordinarily well-tolerated and extraordinarily effective, my hope is that we can make CLL a chronic disease, sort of akin to high blood pressure where patients are able to take a pill a day and keep it in check," said Furman.

The company that makes idelalisib has asked U.S. regulators to approve the drug within six months so it can be made available to people with chronic lymphocytic leukemia.  An article on idelalisib is published in The New England Journal of Medicine.  

You May Like

Karzai's Legacy: Missed Opportunities?

Afghanistan's president leaves behind a much different nation than the one he inherited, yet his legacy from 13 years in power is getting mixed reviews More

Video Secret Service Chief Under Fire for White House Security Breach

Julia Pierson faces tough questions from lawmakers after recent intrusion at White House, says: 'It is clear that our security plan was not executed properly' More

Frustrated, Liberian Students Want Ebola Fight Role

Thousands have volunteered to go to counties, rural villages to talk to people in their language about deadly virus More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Malaysia Struggles to Stop People Joining Jihadi
X
Mahi Ramakrishnan
September 30, 2014 2:16 PM
Malaysian authorities say militant groups like the so-called "Islamic State" have used social media to entice at least three dozen Malaysian Muslims to fight in what they call "jihad" in Syria and Iraq. As Mahi Ramkrishnan reports from Kuala Lumpur, counterterrorism police are deeply worried about what could happen when these militants return home.
Video

Video Malaysia Struggles to Stop People Joining Jihad

Malaysian authorities say militant groups like the so-called "Islamic State" have used social media to entice at least three dozen Malaysian Muslims to fight in what they call "jihad" in Syria and Iraq. As Mahi Ramkrishnan reports from Kuala Lumpur, counterterrorism police are deeply worried about what could happen when these militants return home.
Video

Video Could US Have Done More to Stop Rise of Islamic State?

President Obama says airstrikes against Islamic State militants in Syria will likely continue for some time because, in his words, "there is a cancer that has grown for too long." So what if President Obama had acted sooner in Syria to arm more-moderate opponents of both the Islamic State and the Syrian government? VOA State Department Correspondent Scott Stearns reports from the United Nations.
Video

Video Treasure Hunters Seek 'Hidden Treasure' in Central Kenya

Could a cave in a small village in central Kenya be the site of buried treasure? A rumor of riches, left behind by colonialists, has some residents dreaming of wealth, while others see it as a dangerous hoax. VOA's Gabe Joselow has the story.
Video

Video Iran's Rouhani Skeptical on Syria Strikes

Iranian President Hassan Rouhani expressed skepticism Friday that U.S.-led airstrikes in Iraq and Syria could crush Islamic State militants. From New York, VOA’s Margaret Besheer reports the president was also hopeful that questions about Iran’s nuclear program could be resolved soon.
Video

Video US House Speaker: Congress Should Debate Authorization Against IS

As wave after wave of U.S. airstrikes target Islamic State militants, the speaker of the Republican-controlled House of Representatives says he would be willing to call Congress back into session to debate a formal, broad authorization for the use of military force. VOA’s Michael Bowman reports from Washington, where legislators left town 10 days ago for a seven-week recess.
Video

Video Ebola Patients Find No Treatment at Sierra Leone Holding Center

At a holding facility in Makeni, central Sierra Leone, dozens of sick people sit on the floor in an empty university building. They wait in filthy conditions. It's a 16-hour drive by ambulance to Kailahun Ebola treatment center. Adam Bailes was there and reports on what he says are some of the worst situations he has seen since the beginning of this Ebola outbreak. And he says it appears case numbers may already be far worse than authorities acknowledge.
Video

Video Identifying Bodies Found in Texas Border Region

Thousands of immigrants have died after crossing the border from Mexico into remote areas of the southwestern United States in recent years. Local officials in south Texas alone have found hundreds of unidentified bodies and buried them in mass graves in local cemeteries. Now an anthropologist and her students at Baylor University have been exhuming bodies and looking for clues to identify them. VOA’s Greg Flakus has more from Waco, Texas.
Video

Video Ebola Robs Liberians of Chance to Say Good-Bye to Loved Ones

In Liberia, where Ebola has killed more than 1,500 people, authorities have worked hard to convince people to allow specialized burial teams to take away dead bodies. But these safety measures, while necessary, make it hard for people to say good bye to their loved ones. VOA's Anne Look reports on the tragedy from Liberia.
Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.

AppleAndroid